1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: Meta-regression analysis of follow-up time affecting heterogeneity (tirofiban versus DAPT)
Variable Coefficient (95% CI) Standard Error T P Value
Thromboembolic complications 0.005 (−0.005–0.014) 0.004 1.160 .285
Hemorrhagic complications 0.002 (−0.078–0.116) 0.004 0.460 .656
Perioperative mortality related to antiplatelet medication 0.007 (−0.03–0.017) 1.710 1.710 .131
Good clinical outcomes –0.006 (−0.017–0.006) 0.005 −1.210 .281

Variable	Coefficient (95% CI)	Standard Error	T	P Value
Thromboembolic complications	0.005 (−0.005–0.014)	0.004	1.160	.285
Hemorrhagic complications	0.002 (−0.078–0.116)	0.004	0.460	.656
Perioperative mortality related to antiplatelet medication	0.007 (−0.03–0.017)	1.710	1.710	.131
Good clinical outcomes	–0.006 (−0.017–0.006)	0.005	−1.210	.281